Genetic finding implicates innate immune system in major cause of blindness

Oct 07, 2008

Scientists have identified one of the genes implicated in age-related macular degeneration, the most common cause of blindness in developed countries.

The research, published online today in the Lancet, adds to the growing understanding of the genetics of age-related macular degeneration (AMD), which the researchers believe should ultimately lead to novel treatments for the disease.

Almost two-thirds of people aged 80 years or older are affected by AMD to some degree, with more than one in ten left blind by the disease. In the UK, the annual economic burden from the disease has been estimated to be as high as £80 million, a figure set to increase as our ageing population expands. The total yearly costs of health-care usage are seven-times higher for patients with AMD than for those unaffected.

Researchers have previously identified a number of other genes or genetic loci (regions of the genome) which affect a person's susceptibility to the disease. Now, in research part-funded by the Wellcome Trust, researchers at the University of Southampton have shown that a particular variant of the gene SERPING1, carried by just under a quarter of the population, appears to offer protection against the disease.

The University of Southampton team and colleagues from the University of Iowa found evidence of proteins expressed by SERPING1 in the retina and the choroid layer (the vascular layer next to the retina), the two areas affected by AMD. These proteins are involved in regulating a part of the body's innate immune system known as the "complement system". The findings suggest that the complement system is malfunctioning, attacking the retina and choroid layer.

"It seems counterintuitive that a generalised innate immunity defence system should result in a localised disease of the eye in the elderly," Says Professor Andrew Lotery from the University of Southampton, corresponding author on the study. "However, it is becoming increasingly clear from research that this is the case. Previous AMD genes have already implicated the 'alternate' complement pathway, and our paper shows that the 'classical' complement pathway is also involved in this process."

Source: Wellcome Trust

Explore further: Scientists identify mutation associated with cleft palate in humans and dogs

add to favorites email to friend print save as pdf

Related Stories

Hands-on supercomputing

Aug 21, 2012

Almoutaz El Hassan, a researcher from The University of Texas at San Antonio, develops rainfall–runoff modeling tools to help officials manage issues like flood management and water conservation.

New cause of blindness discovered by scientists

Sep 21, 2010

University of Manchester scientists have discovered a new cause of age-related macular degeneration (AMD), a condition that affects more than 50 million people worldwide and results in blindness.

Hyperactive immune resistance brings blindness in old age

Jul 24, 2008

Age-dependent macular degeneration (AMD) is the commonest cause of blindness in the western industrialised nations. Hereditary changes in the regulation of the immune system influence the risk of contracting AMD. Opthalmologists ...

Cell's 'power plant' genes raise vision disorder risk

May 07, 2008

Genetic variation in the DNA of mitochondria – the “power plants” of cells – contributes to a person’s risk of developing age-related macular degeneration (AMD), Vanderbilt investigators report May 7 in the journal ...

Gene variant increases risk of blindness

Jul 18, 2007

Researchers have found a gene variant that can more than double the risk of developing the degenerative eye disease, age-related macular degeneration.

Recommended for you

User comments : 0